StockDriftsStockDriftsTop 19 Bain Capital Life Sciences Investors LLC Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| HTFL | HEARTFLOW INC | 22.93% | 10.45M | $254.2M | -16.07%(-2.00M) | $33.66(-16.92%) | 2026-03-31 | |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 21.09% | 7.31M | $233.9M | +0.00%(+0) | $11.11(+213.41%) | 2026-03-31 | |
| OLMA | OLEMA PHARMACEUTICALS INC | 10.05% | 7.47M | $111.4M | -12.17%(-1.04M) | $10.55(+19.81%) | 2026-03-31 | |
| SVRA | SAVARA INC | 8.67% | 17.60M | $96.1M | +0.00%(+0) | $2.75(+126.44%) | 2026-03-31 | |
| PHVS | PHARVARIS N V | 6.82% | 2.68M | $75.6M | -4.52%(-126.57K) | $22.17(+52.70%) | 2026-03-31 | |
| SLDB | SOLID BIOSCIENCES INC | 6.37% | 9.81M | $70.6M | +23.98%(+1.90M) | $10.51(+3.13%) | 2026-03-31 | |
| XFOR | X4 PHARMACEUTICALS INC | 2.97% | 7.97M | $32.9M | +0.00%(+0) | $8.80(-53.08%) | 2026-03-31 | |
| DNTH | DIANTHUS THERAPEUTICS INC | 2.74% | 362.5K | $30.4M | -51.25%(-381.12K) | $20.25(+365.76%) | 2026-03-31 | |
| ANNX | ANNEXON INC | 2.6% | 5.21M | $28.9M | -0.69%(-36.40K) | $14.01(-61.04%) | 2026-03-31 | |
| KYTX | KYVERNA THERAPEUTICS INC | 2.42% | 3.11M | $26.8M | +0.00%(+0) | $24.31(-63.44%) | 2026-03-31 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative |
|---|---|---|
| Top 20 Holdings Weighted | +27.42% | +106.88% |
| Top 20 Holdings Unweighted | +34.59% | +143.79% |
Sign up free to track Bain Capital Life Sciences Investors LLC, compare funds side by side, and get alerts the moment positions change.